Offer - Urjas Oil for just ₹ 1 X
Meganeuron PG is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Meganeuron PG safe for pregnant women?
Meganeuron PG is safe for pregnant women.
Is the use of Meganeuron PG safe during breastfeeding?
Breastfeeding women can safely use Meganeuron PG.
What is the effect of Meganeuron PG on the Kidneys?
Very few cases of side effects of Meganeuron PG on kidney have been reported.
What is the effect of Meganeuron PG on the Liver?
The liver can be affected by Meganeuron PG. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Meganeuron PG only after medical advice.
What is the effect of Meganeuron PG on the Heart?
Information about safety of Meganeuron PG for heart is not available since scientific research on this is yet to be done.
Meganeuron PG should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Meganeuron PG unless your doctor advises you to do so -
Is this Meganeuron PG habit forming or addictive?
No, you will not get addicted to Meganeuron PG.
Interaction between Food and Meganeuron PG
Meganeuron PG may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Meganeuron PG
Due to lack of research, there is no information about the side effects of taking Meganeuron PG with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420